ATE218122T1 - Biphenylverbindungen sowie ihre anwendung als östrogene mittel - Google Patents
Biphenylverbindungen sowie ihre anwendung als östrogene mittelInfo
- Publication number
- ATE218122T1 ATE218122T1 AT97902408T AT97902408T ATE218122T1 AT E218122 T1 ATE218122 T1 AT E218122T1 AT 97902408 T AT97902408 T AT 97902408T AT 97902408 T AT97902408 T AT 97902408T AT E218122 T1 ATE218122 T1 AT E218122T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- biphenyl compounds
- estrogenic agents
- sec
- date
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
- C07C39/38—Halogenated derivatives with at least one hydroxy group on a condensed ring system containing two rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9601212A FR2744444B1 (fr) | 1996-02-01 | 1996-02-01 | Nouveaux composes biphenyles, procede et intermediaires de preparation, application a titre de medicaments et compositions pharmaceutiques les renfermant |
PCT/FR1997/000184 WO1997028116A1 (fr) | 1996-02-01 | 1997-01-30 | Composes biphenyles et leur utilisation comme agents estrogeniques |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE218122T1 true ATE218122T1 (de) | 2002-06-15 |
Family
ID=9488725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97902408T ATE218122T1 (de) | 1996-02-01 | 1997-01-30 | Biphenylverbindungen sowie ihre anwendung als östrogene mittel |
Country Status (10)
Country | Link |
---|---|
US (2) | US6147119A (de) |
EP (1) | EP0880496B1 (de) |
JP (1) | JP4143122B2 (de) |
AT (1) | ATE218122T1 (de) |
DE (1) | DE69712868T2 (de) |
DK (1) | DK0880496T3 (de) |
ES (1) | ES2175337T3 (de) |
FR (1) | FR2744444B1 (de) |
PT (1) | PT880496E (de) |
WO (1) | WO1997028116A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6914074B2 (en) * | 2001-12-13 | 2005-07-05 | Wyeth | Substituted phenyl naphthalenes as estrogenic agents |
CA2592543A1 (en) * | 2004-12-31 | 2006-07-13 | Aventis Pharmaceuticals Inc. | Use of selected compounds for protection of neurones and oligodendrocytes in the treatment of multiple sclerosis |
MX2007006797A (es) * | 2004-12-31 | 2007-08-07 | Aventis Pharma Inc | Uso de ciertos compuestos de fenil-naftilo que no tienen afinidad significativa por er alfa o beta para la proteccion de neuronas y oligodendrocitos en el tratamiento de esclerosis multiple. |
AU2005323163A1 (en) * | 2005-01-04 | 2006-07-13 | Aventis Pharmaceuticals Inc. | Use of certain phenyl napthyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (MS) |
JP4590637B2 (ja) * | 2006-02-16 | 2010-12-01 | 国立大学法人 千葉大学 | ベンゼン誘導体の製造方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0532579A (ja) * | 1991-08-01 | 1993-02-09 | Banyu Pharmaceut Co Ltd | エストロゲン物質be−25327及びその製造法 |
-
1996
- 1996-02-01 FR FR9601212A patent/FR2744444B1/fr not_active Expired - Fee Related
-
1997
- 1997-01-30 ES ES97902408T patent/ES2175337T3/es not_active Expired - Lifetime
- 1997-01-30 JP JP52736697A patent/JP4143122B2/ja not_active Expired - Fee Related
- 1997-01-30 EP EP97902408A patent/EP0880496B1/de not_active Expired - Lifetime
- 1997-01-30 PT PT97902408T patent/PT880496E/pt unknown
- 1997-01-30 US US09/117,634 patent/US6147119A/en not_active Expired - Lifetime
- 1997-01-30 DE DE69712868T patent/DE69712868T2/de not_active Expired - Lifetime
- 1997-01-30 WO PCT/FR1997/000184 patent/WO1997028116A1/fr active IP Right Grant
- 1997-01-30 AT AT97902408T patent/ATE218122T1/de not_active IP Right Cessation
- 1997-01-30 DK DK97902408T patent/DK0880496T3/da active
-
2000
- 2000-07-27 US US09/627,023 patent/US6365775B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR2744444B1 (fr) | 1998-05-29 |
PT880496E (pt) | 2002-10-31 |
US6365775B1 (en) | 2002-04-02 |
ES2175337T3 (es) | 2002-11-16 |
JP2000504003A (ja) | 2000-04-04 |
DE69712868T2 (de) | 2002-11-28 |
JP4143122B2 (ja) | 2008-09-03 |
US6147119A (en) | 2000-11-14 |
FR2744444A1 (fr) | 1997-08-08 |
DE69712868D1 (de) | 2002-07-04 |
DK0880496T3 (da) | 2002-09-09 |
WO1997028116A1 (fr) | 1997-08-07 |
EP0880496B1 (de) | 2002-05-29 |
EP0880496A1 (de) | 1998-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1276071B1 (it) | Compositi ad attivita' anti-infiammatoria | |
FI970920A0 (fi) | Trifenyylietyleenejä käytettäväksi osteoporoosin ehkäisyyn ja hoitoon | |
DE69523169D1 (de) | Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung | |
BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
TR199900501T2 (xx) | Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�. | |
FI973221A (fi) | 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina | |
ATE242769T1 (de) | Verfahren zur herstellung von 2-(3-pyrazolyl- oxymethylen)nitrobenzolen | |
NO982778D0 (no) | Morfinderivater med smertestillende virkning | |
DE69611728T2 (de) | N-(4-substituerte benzyl)-2-aminolactamderivate | |
GEP20043227B (en) | 5HT1 Antagonists for Antidepressant Therapy | |
ATE218122T1 (de) | Biphenylverbindungen sowie ihre anwendung als östrogene mittel | |
DK0891341T3 (da) | 1,3,4-Oxadiazinderivater samt deres anvendelse som pesticider | |
DE59510713D1 (de) | N-substituierte 3-azabicyclo(3.2.0)heptan-derivate als neuroleptika | |
ATE345117T1 (de) | Biphenylverbindungen sowie ihre anwendung als östrogene mittel | |
BR9814495A (pt) | Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo | |
PT775143E (pt) | Novos derivados de 3h-2,3-benzodiazepina 3-substituidos sua preparacao e utilizacao | |
ATE215525T1 (de) | Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung | |
SE9302218D0 (sv) | New use | |
DK0891326T3 (da) | Nye D-vitaminanaloger | |
ATE173471T1 (de) | Pyridazinonderivate oder deren salze, verfahren zu ihrer herstellung und diese enthaltende antischockmittel | |
BR9807785A (pt) | Processo para a preparação do composto, e, composto | |
SE9401596D0 (sv) | New compounds | |
SE9404438D0 (sv) | New process | |
SE9603284D0 (sv) | New compounds | |
ES2122274T3 (es) | Derivados de pirido(1,2,3-de)quinoxalina, procedimiento para su produccion y su uso en medicamentos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |